Advertisement

Stability of attenuated poliovirus strain genotypes in the human intestinal tract

  • P. Minor
  • G. Dunn
  • J. W. Almond
  • A. Macadam

Summary

The major part of the attenuation of the live poliovirus vaccine strains of Sabin is attributable to differences from virulent strains at two or three bases. The mutations revert or are suppressed by second site mutations in vaccine recipients with varying degrees of rapidity and to varying extents, employing both point mutation and recombination. Despite the high degree of genetic variability of the virus, vaccine associated paralysis is very rare.

Keywords

Vaccine Strain Oral Poliovirus Vaccine Oral Poliovaccine Post Immunisation Paralytic Poliomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Assaad F, Cockburn WC (1982) The relation between acute persisting spinal paralysis and poliomyelitis vaccine -results of a ten-year enquiry. Bull WHO 60: 231–242Google Scholar
  2. 2.
    Cammack N, Phillips A, Dunn G, Patel V, Minor PD (1989) Intertypic genomic rearrange ments of poliovirus strains in vaccinees. Virology 167: 507–514Google Scholar
  3. 3.
    Christodoulou C, Golbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor PD, Horaud F (1990) Mapping of mutations associated with monkey neurovirulence of Sabin 1 poliovirus revertants selected at high temperature. J Virol 64:4922–4929PubMedGoogle Scholar
  4. 4.
    Dunn G, Begg NT, Cammack N, Minor PD (1990) Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 32: 92–95PubMedCrossRefGoogle Scholar
  5. 5.
    Evans DMA, Dunn G, Minor PD, Schild GG, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV (1985) A single nucleotide change in the 5’ noncoding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence. Nature 314: 548–550PubMedCrossRefGoogle Scholar
  6. 6.
    Filman DJ, Syed R, Chow M, Minor PD, Macadam AJ, Hogle J (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO Journal 8:1567–1579PubMedGoogle Scholar
  7. 7.
    Lipskaya GY, Muzychenko AR, Kutitova OK, Maslova SV, Equestre M, Drozdov SG, Perez-Besof TR, Agol VI (1991) J Med Virol 35: 290–296PubMedCrossRefGoogle Scholar
  8. 8.
    Macadam AJ, Arnold C, Howlett J, John A, Marsden S, Taffs F, Reeve P, Hamada N, Wareham K, Almond J, Cammack N, Minor PD (1989) Reversion of attenuated and temperature sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 174: 408–414CrossRefGoogle Scholar
  9. 9.
    Macadam AJ, Ferguson G, Burlison J, Stone D, Skuce R, Almond JW, Minor PD (1993) Correlation of RNA structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology (in press)Google Scholar
  10. 10.
    Minor PD, Schild GC (1981) Identification of the origin of poliovirus isolates. Report of World Health Organization informal meetings 1978–1980. Lancet i: 968–969Google Scholar
  11. 11.
    Minor PD, John A, Ferguson M, Icenogle JP (1986) Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67: 693–706PubMedCrossRefGoogle Scholar
  12. 12.
    Minor PD, Dunn G (1988) The effect of sequences in the 5’ non coding region on the replication of polioviruses in the human gut. J Gen Virol 69: 1091–1096PubMedCrossRefGoogle Scholar
  13. 13.
    Minor PD, Dunn G, Evans DMA, Magrath DI, John A, Howlett J, Phillips A, Westrop G, Wareham K, Almond JW, Hogle J (1989) The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in capsid protein VP3. J Gen Virol 70: 1117–1123PubMedCrossRefGoogle Scholar
  14. 14.
    Nkowane BM, Wassilak SG, Oversteen WA, Bart KJ, Schonberger LB, Hinman AR, Kew OM (1987) Vaccine associated paralytic poliomyelitis United States. 1973 through 1984. J Am Med Ass 257: 1335–1340CrossRefGoogle Scholar
  15. 15.
    Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler BC, Kameda A, Itoh H, Arita M, Wimmer E, Nomoto A (1986) Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol 58: 348–358PubMedGoogle Scholar
  16. 16.
    Pollard SR, Dunn G, Gammack N, Minor PD, Almond JW (1989) Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol 63: 4949–4951PubMedGoogle Scholar
  17. 17.
    Racaniello VR, Baltimore D (1981) Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916–919PubMedCrossRefGoogle Scholar
  18. 18.
    Ricoh-Hesse R, Pallansch MA, Nottay BK, Kew OM (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160: 311–322CrossRefGoogle Scholar
  19. 19.
    Sabin AB, Boulger LR (1973) History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1: 115–118CrossRefGoogle Scholar
  20. 20.
    Salk JE (1960) Persistence of immunitye after administration of formalin treated poliovirus vaccine. Lancet ii: 715–723CrossRefGoogle Scholar
  21. 21.
    Skinner MA, Racaniello VR, Dunn G, Cooper J, Minor PD, Almond JW (1989) A new model for the secondary of the 5’ non coding RNA of poliovirus is supported by biochemical and genetical data which also show that RNA secondary structure is important in neuroviiulence. J Mol Biol 207: 379–392PubMedCrossRefGoogle Scholar
  22. 22.
    Stanway G, Hughes PJ, Mountford RC, Reeve P, Minor PD, Schild GC, Almond JW (1984) Comparison of the complete nucleotide sequence of the genomes of the neurovirulent poliovirus P3/Leon/37 ant its attenuated Sabin vaccine derivative P3/Leon/12a,b. Proc Natl Acad Sci USA 81: 1539–1543PubMedCrossRefGoogle Scholar
  23. 23.
    Svitkin YV, Maslova TV, Agol VI (1985) The genomes of attenuated and virulence poliovirus strains differ in their in vitro translation efficiencies. Virology 147: 243–252PubMedCrossRefGoogle Scholar
  24. 24.
    Svitkin YV, Pestova TV, Maslova SV, Agol VI (1988) Point mutations modify the response of poliovirus RNA to a translation on initiation factor: a comparison of neuro virulent and attenuated strains. Virology 166: 394–404PubMedCrossRefGoogle Scholar
  25. 25.
    Svitkin Y, Cammack N, Minor PD, Almond JW (1990) Translation deficiency of the Sabin type 3 poliovirus genome: associations with an attenuating mutation C472-V Virology 175: 103–109PubMedCrossRefGoogle Scholar
  26. 26.
    Tatem JM, Weeks-Levy C, Georgia A, DiMichele SJ, Gorgaez EJ, Racaniello VR, Cano FR, Mento SJ (1992) A mutation present in the amino terminus of Sabin 3 poliovirus VP1 proteins is attenuating. J Virol 66: 3194–3197PubMedGoogle Scholar
  27. 27.
    van der Werf S, Bradley J, Wimmer E, Studier FW, DunnJJ (1986) Synthesis of infectious poliovirus RNA by purified T7 polymerase. Proc Natl Acad Sci USA 83: 2330–2334PubMedCrossRefGoogle Scholar
  28. 28.
    Weeks-Levy C, Tatem JM, DiMichele SJ, Waterfield W, Georgia AF, Mento SJ (1991) Idenification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus. Virology 185: 934–937PubMedCrossRefGoogle Scholar
  29. 29.
    Westrop GD, Evans DMA, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Wareham KA, Skinner M, Schild GC, Almond JW (1989) Genetic basis of attenuation of the Sabin type 3 oral polio vaccine. J Virol 63: 1338–1344PubMedGoogle Scholar
  30. 30.
    WHO (1969) Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus. Bull WHO 40: 925–945Google Scholar
  31. 31.
    WHO (1983) Requirements for poliomyelitis vaccine (oral) (Revised 1982). Technical Report Series 687: 107–174; World Health Organisation, GenevaGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1993

Authors and Affiliations

  • P. Minor
    • 1
  • G. Dunn
    • 1
  • J. W. Almond
    • 2
  • A. Macadam
    • 1
  1. 1.National Institute for Biological Standards and ControlSouth Mimms, Potters Bar, HertsUK
  2. 2.University of ReadingWhitenightsUK

Personalised recommendations